Blood filter could be key to saving lives in High-Risk transplants
NCT ID NCT07200583
Summary
This study looked back at 50 patients with blood cancers or disorders who received a stem cell transplant from a half-matched family donor. Before the transplant, some patients received a treatment that filters harmful antibodies from their blood, sometimes with added drugs. The goal was to see if this helped the donor cells successfully take hold, reduced complications like graft failure or infections, and improved short-term survival.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for HEMATOLOGIC MALIGNANCIES are added.
Genom att skicka in godkänner du våra Användarvillkor
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
Genom att skicka in godkänner du våra Användarvillkor
Locations
-
The First Affiliated Hospital of Fujian Medical University, Fuzhou, Fujian 350001
Fuzhou, Fujian, China
Conditions
Explore the condition pages connected to this study.